000			02073 a2200565 4500
005			20250517093823.0
264		0	_c20180214
008			201802s 0 0 eng d
022			_a1815-7920
024	7		_a10.5588/ijtld.15.0577 _2doi
040			_aNLM _beng _cNLM
100	1		_aJindani, A
245	0	0	_aA randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. _h[electronic resource]
260			_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _c06 2016
300			_a832-8 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntitubercular Agents _xtherapeutic use
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEthambutol _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aIsoniazid _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPatient Compliance
650	0	4	_aPyrazinamide _xtherapeutic use
650	0	4	_aRifampin _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aTuberculosis, Pulmonary _xdrug therapy
650	0	4	_aYoung Adult
700	1		_aBorgulya, G
700	1		_ade Patiño, I Westermann
700	1		_aGonzales, T
700	1		_ade Fernandes, R A
700	1		_aShrestha, B
700	1		_aAtwine, D
700	1		_aBonnet, M
700	1		_aBurgos, M
700	1		_aDubash, F
700	1		_aPatel, N
700	1		_aCheckley, A M
700	1		_aHarrison, T S
700	1		_aMitchison, D
773	0		_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 20 _gno. 6 _gp. 832-8
856	4	0	_uhttps://doi.org/10.5588/ijtld.15.0577 _zAvailable from publisher's website
999			_c25997199 _d25997199